Upadacitinib for treating moderate to severe atopic dermatitis in people aged 12 and over [ID3733]

£656.3K GBP

Funder	National Institute for Health Research
Recipient Organization	Bmj Publishing Group Limited
Country	United Kingdom
Start Date	Feb 11, 2021
End Date	Aug 04, 2021
Duration	174 days
Number of Grantees	1
Roles	Award Holder
Data Source	Europe PMC
Grant ID	`NIHR134010`

Grant Description

To appraise the clinical and cost effectiveness of upadacitinib within its marketing authorisation for treating moderate to severe atopic dermatitis in people aged 12 and over.